United Therapeutics Corporation Deferred Tax Assets, Unrealized Losses on Trading Securities
United Therapeutics Corporation (UTHR) had Deferred Tax Assets, Unrealized Losses on Trading Securities of $2.10 million as of 2012-12-31, per its 10-K filed 2014-02-25.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities · last filed 2014-02-25
- 2012-12-31: Deferred Tax Assets, Unrealized Losses on Trading Securities $2.10M.
- 2011-12-31: Deferred Tax Assets, Unrealized Losses on Trading Securities $2.10M.
- 2010-12-31: Deferred Tax Assets, Unrealized Losses on Trading Securities $2.73M.
| Period end | Deferred Tax Assets, Unrealized Losses on Trading Securities |
|---|---|
| 2012-12-31 | $2.10M 10-K · filed 2014-02-25 |
| 2011-12-31 | $2.10M 10-K · filed 2013-02-26 |
| 2010-12-31 | $2.73M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |